By Abigail Townsend
Date: Monday 22 Sep 2025
(Sharecast News) - Pfizer Inc has agreed to buy biotech Metsera in multi-billion dollar deal, the US drugs giant confirmed on Monday, giving it a foothold in the booming weight-loss sector and sending shares in the start-up soaring.
Currency | US Dollars |
Share Price | $ 754.95 |
Change Today | $ 2.96 |
% Change | 0.39 % |
52 Week High | $932.06 |
52 Week Low | $625.65 |
Volume | 2,527,396 |
Shares Issued | 948.17m |
Market Cap | $715,821m |
Beta | 0.67 |
RiskGrade | 179 |
Strong Buy | 11 |
Buy | 10 |
Neutral | 8 |
Sell | 0 |
Strong Sell | 0 |
Total | 29 |
Time | Volume / Share Price |
15:59 | 100 @ $755.21 |
15:59 | 100 @ $755.26 |
15:59 | 100 @ $755.25 |
15:59 | 100 @ $755.32 |
15:58 | 100 @ $756.20 |
You are here: research